• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. ORBERA INTRAGASTRIC BALLOON SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. ORBERA INTRAGASTRIC BALLOON SYSTEM Back to Search Results
Model Number B-50000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Blood Loss (2597); Patient Problem/Medical Problem (2688)
Event Date 08/28/2017
Event Type  Injury  
Manufacturer Narrative
The reporter confirmed the explanted device will not be return to apollo for analysis.Further information has been requested from the reporter regarding patient outcome and medical history, however to date no additional information has been received by apollo.A review of the device labeling finds the following: contraindications: potential upper gastrointestinal bleeding conditions such as esophageal or gastric varices, congenital or acquired intestinal telangiectasis, or other congenital anomalies of the gastrointestinal tract such as atresias or stenoses.Warnings and precautions: the physiological response of the patient to the presence of the orbera® system balloon may vary depending upon the patient's general condition and the level and type of activity.The types and frequency of administration of drugs or diet supplements and the overall diet of the patient may also affect the response.Each patient must be monitored closely during the entire term of treatment in order to detect the development of possible complications.Each patient should be instructed regarding symptoms of deflation, gastrointestinal obstruction, ulceration and other complications which might occur, and should be advised to contact his/her physician immediately upon the onset of such symptoms.Possible complications of the use of the orbera® system include: injury to the digestive tract during placement of the balloon in an improper location such as in the esophagus or duodenum.This could cause bleeding or even perforation, which could require a surgical correction for control.Injury to the lining of the digestive tract as a result of direct contact with the balloon, grasping forceps, or as a result of increased acid production by the stomach.This could lead to ulcer formation with pain, bleeding or even perforation.Surgery could be necessary to correct this condition.Orbera® system placement and inflation: 1.Prepare the patient according to hospital protocol for gastroscopy.2.Perform gastroscopic inspection of esophagus and stomach.3.Remove gastroscope.4.Where there are no contraindications: a.Lubricate the orbera® system placement sheath with surgical lube-gel.B.Move the orbera® system gently down the esophagus and into the stomach.5.Reinsert the endoscope while the balloon is in situ to observe filling steps.The balloon must be below the lower esophageal sphincter and well within the stomach cavity.
 
Event Description
Reported as: a patient with the orbera intragastric balloon presented with bleeding from what seemed to be a deulafoy's similar lesion that was observed in the fundus.The bleeding was characterized as life-threatening.Device was removed.The patient had multiple transfusions and endoscopic treatment.The patient had "gastroskopi with heamostase to stop bleeding" and was admitted to the intensive care because of blood loss.The physician stated the event was not procedure related however the cause is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA INTRAGASTRIC BALLOON SYSTEM
Type of Device
INTRAGASTRIC BALLOON
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s capitol of texas hwy
bldg 1, ste 300
austin TX 78746
Manufacturer (Section G)
APOLLO ENDOSURGERY COSTA RICA, SRL
coyol free zone
building b 13.3
alajuela, costa rica
CS  
Manufacturer Contact
laura leboeuf
1120 s capitol of texas hwy
bldg 1, ste 300
austin, TX 78746
5122795100
MDR Report Key7304415
MDR Text Key101208323
Report Number3006722112-2018-00080
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeDA
PMA/PMN Number
P140008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial
Report Date 01/31/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date05/15/2019
Device Model NumberB-50000
Device Catalogue NumberB-50000
Device Lot NumberAF00756
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/31/2018
Initial Date FDA Received02/28/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/15/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age38 YR
-
-